Skip to main content

20700Ul Axca (Ultresa 41,400 USP units amylase; 20,700 USP units lipase; 41,400 USP units protease)

Generic Name: pancrelipase

Pill with imprint 20700Ul Axca is Gray / White, Capsule-shape and has been identified as Ultresa 41,400 USP units amylase; 20,700 USP units lipase; 41,400 USP units protease. It is supplied by Allergan, Inc.

Ultresa is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultresa 41,400 USP units amylase; 20,700 USP units lipase; 41,400 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for 20700Ul Axca

Ultresa

Generic Name
pancrelipase
Imprint
20700Ul Axca
Strength
41,400 USP units amylase; 20,700 USP units lipase; 41,400 USP units protease
Color
Gray / White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Allergan, Inc.
National Drug Code (NDC)
58914-0019 (Discontinued)
Inactive Ingredients
silicon dioxide, croscarmellose sodium, hydrogenated castor oil, hypromellose phthalate, magnesium stearate, microcrystalline cellulose, magnesium silicate, triethyl citrate, gelatin, titanium dioxide, ferrosoferric oxide, shellac, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.